Cilostazol
NDC 70436-157, cilostazol, tablet, from Slate Run Pharmaceuticals, LLC.
- Product NDC
- 70436-157
- Status
- Listed
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077208
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70436-157 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CILOSTAZOL100 mg/1
Pharmacologic classes
Phosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 3 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70436-157-06 | 70436015706 | 60 TABLET in 1 BOTTLE (70436-157-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/db0278e9-4ece-4aaf-9216-6bcbec58206aNADAC price for package 70436015706
GET /v1/drugs/nadac/70436015706
Use it
Look up 70436-157 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70436-157 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70436-157. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.